SOR-C13

SOR-C13 · Soricimed Biopharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SOR-C13, covering 2016-06-23 to 2016-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel [Phase 1]

See pricing